V
Vineti
Biotech & Life Sciences · San Francisco, United States · Founded 2016
The essential software solution to drive and scale personalized therapies, such as Cell and Gene Therapies or Cancer Vaccines MoreLess
Vineti is a technology startup that provides a comprehensive platform designed to manage the complex workflows involved in personalized cell and gene therapies. The company serves biopharmaceutical and life science companies, focusing on the development and delivery of personalized medicines for patients with complex diseases. Operating in the personalized medicine market, Vineti's business model revolves around offering a robust, agnostic platform that integrates various aspects of the therapy ecosystem, including manufacturing, supply chain, quality control, IT, commercial, and regulatory teams. The platform ensures full transparency, traceability, and control from specimen collection to the delivery of the final product to the patient. Vineti generates revenue through subscription fees for its software solutions and partnerships with therapy developers. The company aims to optimize resources, speed up deployment, and ensure the highest level of care and transparency in the therapeutic process.
Keywords: personalized medicine, cell therapy, gene therapy, biopharmaceutical, life sciences, workflow management, transparency, traceability, supply chain, regulatory compliance.
Company overview
Vineti company information
The essential company record, classifications and operating signals in one place.
- Status
- Closed
- Founded
- 2016
- Headquarters
- San Francisco, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 0.0
Valuation & funding
Vineti funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Oct 2020 | $33M | $175M | Threshold Ventures · Canaan · Casdin Capital · McKesson Ventures | — |
| SERIES COther financing | Feb 2020 | $35M | $140M | Canaan · Kite Pharma · Lifeforce Capital · Cardinal Health | ↗ |
| SERIES BOther financing | Apr 2018 | $34M | $134M | Lifeforce Ventures · Section 32 · Threshold Ventures · GE Ventures | ↗ |
| SERIES AOther financing | Jun 2017 | $14M | $55M | Threshold Ventures · Lifeforce Ventures · GE Ventures · Mayo Clinic | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 20 |
| 2025 | 24 |
| 2024 | 29 |
| 2023 | 41 |
| 2022 | 98 |
| 2021 | 193 |
| 2020 | 158 |
Growth signals
Vineti website traffic
Latest recorded traffic for Vineti is 600 monthly website visits, up 71.4% over the last three months. Vineti's team declined 16.7% over the past year.
Comparisons
Vineti compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Vineti's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Vineti has talent and traffic
team presence
In the news
Latest news about Vineti
Recent press, funding announcements, and product moves mentioning Vineti — open to read from the original sources.
Market sentiment
What the market is saying about Vineti
An AI-synthesized read of the highest-engagement posts about Vineti on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vineti’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.